Three ASX companies jockeying to be the next biotech winners

  • 📰 FinancialReview
  • ⏱ Reading Time:
  • 40 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 90%

Nigeria News News

Nigeria Nigeria Latest News,Nigeria Nigeria Headlines

Clarity Pharmaceuticals reports it eliminated prostate cancer in a patient; LTR Pharma wants to sell nasal viagra; and Opthea has clinical trial results soon.

To make blockbuster returns in the sharemarket, you’ve got to find the winners of tomorrow, not today.

Clarity Pharmaceuticals is a radiopharmaceuticals medical group which uses radiation to target cancers for diagnostic and treatment purposes. Its product offers radiation against cancer cells by injecting radioisotopes named Cu-64 and Cu-67 into a patient, with its targeted nature meaning it tends to have less chronic side effects than the current standard of care chemotherapy.

Excitement around LTR stock has seen it quadruple in value since its December 2023 IPO and management says its product, named Spontan, works faster as it’s inhaled as a nasal spray, so it gets into the bloodstream quicker. But even if it does get approval, it will face a hard slog selling its product against generic competition that retails for just $13.99 a dose at Chemist Warehouse.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 2. in NG
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Nigeria Nigeria Latest News, Nigeria Nigeria Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

ASX 200 LIVE: ASX to drop, megacap tech earnings in focusShares are poised to drop 0.8 per cent at the start of trade; Biden exit leaves markets asking what’s next for ‘Trump trade’; Alphabet and Tesla report this week. Follow here more.
Source: FinancialReview - 🏆 2. / 90 Read more »